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Chagas disease, which was once thought to be conﬁned to endemic regions of Latin
America, has now gone global becoming a new worldwide challenge. For more than a
century since its discovery, it has remained neglected with no effective drugs or vaccines.
The mechanisms by which Trypanosoma cruzi regulates and uses the extracellular matrix
(ECM) to invade cells and cause disease are just beginning to be understood. Here we
critically review and discuss the regulation of the ECM interactome by T. cruzi, the use of
the ECM by T. cruzi and analyze the molecular ECM/T. cruzi interphase during the early
process of infection. It has been shown that invasive trypomastigote forms ofT. cruzi use
and modulate components of the ECM during the initial process of infection. Infective
trypomastigotes up-regulate the expression of laminin γ-1 (LAMC1) and thrombospondin
(THBS1) to facilitate the recruitment of trypomastigotes to enhance cellular infection.
Silencing the expression of LAMC1 and THBS1 by stable RNAi dramatically reduces try-
panosome infection.T. cruzi gp83, a ligand that mediates the attachment of trypanosomes
to cells to initiate infection, up-regulates LAMC1 expression to enhance cellular infection.
Infective trypomastigotes use Tc85 to interact with laminin, p45 mucin to interact with
LAMC1 through galectin-3 (LGALS3), a human lectin, and calreticulin (TcCRT) to interact
with TSB1 to enhance cellular infection. Silencing the expression of LGALS3 also reduces
cellular infection. Despite the role of the ECM inT. cruzi infection, almost nothing is known
about the ECM interactome networks operating in the process ofT. cruzi infection and its
ligands. Here, we present the ﬁrst elucidation of the human ECM interactome network
regulated by T. cruzi and its gp83 ligand that facilitates cellular infection. The elucidation
of the human ECM interactome regulated by T. cruzi and the dissection of the molecular
ECM/T. cruzi interphase using systems biology approaches are not only critically impor-
tant for the understanding of the molecular pathogenesis of T. cruzi infection but also for
developing novel approaches of intervention in Chagas disease.
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LAMC1 AND THBS1 ARE REQUIRED FOR T. cruzi INFECTION
As part of our efforts to identify the molecular signatures induced
by Trypanosoma cruzi in mammalian cells during the early infec-
tion process, we analyzed the kinetics of the extracellular matrix
Abbreviations: 4A4, gp83 monoclonal antibody that neutralizes T. cruzi infection;
ACHE, acetylcholinesterase (Yt blood group); APCS, amyloid P component, serum;
APP, amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease);
ATF7IP, activating transcription factor 7 interacting protein; ATXN7L2, ataxin 7-like
2; B5,T. cruzi p45 mucin monoclonal antibody; BCAM,basal cell adhesion molecule
(Lutheran blood group); BCL6, B-cell CLL/lymphoma 6; BIND,Biomolecular Inter-
action Network Database; BMP1, bone morphogenetic protein 1; bBTBD10, BTB
(POZ) domain containing 10; C3, complement component 3; CALR or CRT, cal-
reticulin; CCDC53, coiled-coil domain containing 53; CCSB-HI1, Center for cancer
Systems Biology-Human Interactome; CD36, CD36 molecule (thrombospondin
receptor); CD44, CD44 molecule (Indian blood group); CD47, CD47 molecule;
CFH, complement factor H; cGMP, cyclic guanosine monophosphate; COL1A1,
collagen, type I, alpha 1; COL2A1, collagen, type II, alpha 1; COL3A1, collagen,
type III, alpha 1 (Ehlers–Danlos syndrome type IV, autosomal dominant); COL5A1,
collagen, type V, alpha 1; COL6A1, collagen, type VI, alpha 1; COL7A1, colla-
gen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive);
CORO1A, coronin, actin binding protein, 1A; CSNK1A1, casein kinase 1, alpha 1;
(ECM) human transcriptome response. The result of this analysis
showed that the only ECM proteins, LAMC1 and THBS1, were
important in the early infection process. Accordingly, silencing
the expression of LAMC1 and THBS1 by stable RNAi signiﬁcantly
CSNK2A1, casein kinase 2, alpha 1 polypeptide; CSNK2A2, casein kinase 2, alpha
prime polypeptide; CTGF, connective tissue growth factor; CTSG, cathepsin G;
CUBN, cubilin (intrinsic factor-cobalamin receptor); CYHR1, cysteine/histidine-
rich 1; DAG1, dystroglycan 1 (dystrophin-associated glycoprotein 1); DCN,decorin;
DHFR, dihydrofolate reductase; DIP, Database of Interacting Proteins; E3T3C1, C-
terminal domain of TSP-1, containing the last type II repeat domain, the three
type III repeat domains and the carboxy-terminal domain; ECM, extracellular
matrix; EGF, epidermal growth factor; ELA2, elastase 2, neutrophil; ELN, elastin
(supravalvular aortic stenosis, Williams–Beuren syndrome); ERK 1/2, extracellu-
lar signal-regulated kinase; F2, coagulation factor II (thrombin); FBLN2, ﬁbulin
2; FCGR2A, Fc fragment of IgG, low afﬁnity IIa, receptor (CD32); FGA, ﬁbrino-
gen alpha chain; FN1, ﬁbronectin 1; GEMIN4, gem (nuclear organelle) associated
protein 4; GFI1B, growth factor independent 1B transcription repressor; gp83 or
Tcgp83, T. cruzi trypomastigote ligand or trypomastigote surface 83 kDa glyco-
protein; HCASM, human coronary artery smooth muscle cell; HPRD, Human
Protein Reference database; HRG, histidine-rich glycoprotein; HSPG2, heparan
sulfate proteoglycan2; INF-γ, Interferon gamma; IGFBP5, insulin-like growth factor
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reduced T. cruzi infection in cells (Nde et al., 2006; Simmons
et al., 2006). The cells in which stable LAMC1 RNAi or THBS1
RNAi were performed showed signiﬁcant reduction in the protein
expression level of LAMC1 or THBS1 compared to cells stably
transfected with vector alone or scrambled LAMC1 or THBS1 and
the kinetics of T. cruzi infection were also dramatically reduced
(Nde et al., 2006; Simmons et al., 2006). These studies showed
that T. cruzi requires LAMC1 and THBS1 for early infection and
indicated that host LAMC1 and THBS1 play critical roles in the
early process of T. cruzi infection (Nde et al., 2006; Simmons et al.,
2006). The important roles played by LAMC1 and THBS1 encour-
aged our group to dissect their molecular role in T. cruzi infection
by looking at the ECM/T. cruzi interphase and elucidating the
gene-networks and interactomes triggered by T. cruzi and its sur-
face molecules involved in the early infection process (Cardenas
binding protein 5; IL-12, interleukin 12; IPI, International Protein Index; ITGA1,
integrin, alpha 1; ITGA2, integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 recep-
tor); ITGA3, integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor);
ITGA4, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor);
ITGA6, integrin, alpha 6 (alpha subunit of VLA-6 receptor); ITGAV, integrin, alpha
V (vitronectin receptor, alpha polypeptide, antigen CD51); ITGB1, integrin, beta
1 (ﬁbronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12);
ITGB3, integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); ITGB4, inte-
grin, beta 4; JAG1, jagged 1 (Alagille syndrome); KNG1, kininogen 1; KEGG,
Kyoto Encyclopedia of Genes and Genomes; LAMA1, laminin, alpha 1; LAMA2,
laminin, alpha 2 (merosin, congenital muscular dystrophy); LAMA3, laminin,
alpha 3; LAMA5, laminin, alpha 5; LAMB1, laminin, beta 1; LAMB2, laminin,
beta 2 (laminin S); LAMB3, laminin, beta 3; LAMC1, laminin, gamma 1 (for-
merly LAMB2); LAMC2, laminin, gamma 2; LAMC3, laminin, gamma 3; LGALS3,
lectin, galactoside-binding, soluble, 3; LGALS3BP, lectin, galactoside-binding, sol-
uble, 3 binding protein; LIM2, lens intrinsic membrane protein 2, 19kDa; LRP1,
low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor); LRP5,
low density lipoprotein receptor-related protein 5; LTBP1, latent transforming
growth factor beta binding protein 1; MATN2, matrilin 2; MEF, mouse embryo
ﬁbroblast; MEK, mitogen-activated protein kinase kinase; MEP1A, meprin A, alpha
(PABApeptide hydrolase); MiMI,MichiganMolecular Interactions; MMP-2,matrix
metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase);
MMP-9, matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type
IV collagenase); MUC7, mucin 7, secreted; MYOC, myocilin, trabecular meshwork
inducible glucocorticoid response; NID1, nidogen-1; NID2, nidogen-2 (osteonido-
gen); NO, nitric oxide; NT5E, 5′-nucleotidase, ecto (CD73); NTSP, N-terminal
domain of TSP-1; ONECUT1, one cut homeobox 1; PDE1A, phosphodiesterase 1A,
calmodulin-dependent; PDEA, phosphodiesterase 6A, cGMP-speciﬁc, rod, alpha;
PDGFB, platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-
sis) oncogene homolog); PLAT, plasminogen activator, tissue; PLC, phospholipase
C; PLG, plasminogen; PPI, protein–protein interaction; PTPRF, protein tyrosine
phosphatase, receptor type, F; RAF, v-raf-1 murine leukemia viral oncogene; RAS,
rat sarcoma viral oncogene homolog; RNAi, RNA interference; RPSA, ribosomal
protein SA; SAA1, serum amyloid A1; SAA2, serum amyloid A2; SCARB2, scavenger
receptor class B, member 2; SCD4, stearoyl-CoA desaturase 5; SDC1, syndecan
1; SDC3, syndecan 3; SIP1, survival of motor neuron protein interacting protein
1; SMAD2, SMAD family member 2; SNAPIN, SNAP-associated protein; SPARC,
secreted protein, acidic, cysteine-rich (osteonectin); SPP1, secreted phosphopro-
tein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1); SUFU,
suppressor of fused homolog (Drosophila); SV2A, synaptic vesicle glycoprotein
2A; SV2B, synaptic vesicle glycoprotein 2B; SV2C, synaptic vesicle glycoprotein 2C;
Tc45, T. cruzi 45 kDA surface mucin; Tc85, T. cruzi 85 kDa surface glycoprotein;
TcCRT, T. cruzi calreticulin; TFPI, tissue factor pathway inhibitor (lipoprotein-
associated coagulation inhibitor); TGF-α, transforming growth factor alpha; TGF-β,
transforming growth factor beta; TGFB1, transforming growth factor, beta 1; TSP-
1/THBS1, thrombospondin 1; TMPRSS6, transmembrane protease, serine 6; TNFα,
tumor necrosis factor alpha; TNFAIP6, tumor necrosis factor, alpha-induced protein
6; TNFRSF11B, tumor necrosis factor receptor superfamily, member 11b (osteo-
protegerin); TNFRSF1A, tumor necrosis factor receptor superfamily, member 1A;
TRAP; thrombospondin-related anonymous protein; TP53, tumor protein p53;
TSC2, tuberous sclerosis 2; ZNF512B, zinc ﬁnger protein 512B; ZNF8, zinc ﬁnger
protein 8.
et al., 2010; Nde et al., 2010). This will be critically reviewed in the
next sections.
T. cruzi SURFACE GP83 UP-REGULATES LAMC1 TO RECRUIT
PARASITES AT THE ECM TO ENHANCE INFECTION
Gp83 is a ligand expressed in all T. cruzi strains and employed
by the parasite to attach and enter macrophages as well as non-
phagocytic cells (Lima andVillalta, 1988; Villalta et al., 1998, 1999,
2001, 2008). Notably, it is expressed only in invasive trypomastig-
otes (Villalta et al., 1992) and is more expressed in highly infective
trypomastigote clones (Lima and Villalta, 1989). Monovalent Fab
fragments of the gp83-speciﬁc monoclonal antibody 4A4 inhibit
gp83 binding to myoblasts, ﬁbroblasts, and macrophages, block
trypanosomes from attaching to and entering these cells, and
neutralize T. cruzi infection in vivo (Villalta et al., 2001). Trypo-
mastigotes release gp83 via parasite glycosylphosphatidylinositol–
phospholipase C (PLC) cleavage to activate the host MAPK
pathway and PKC in order to promote parasite infection (Villalta
et al., 1998, 1999; Nde et al., 2006).
Exposure of gp83 ligand to human cells increases the level of
LAMC1 transcripts and its expression in mammalian cells, leading
to an increase in cellular infection by T. cruzi (Nde et al., 2006).
This increase in cellular infection was seen as over-attachment
and entry of trypomastigotes into human cells over-expressing
LAMC1, under the inﬂuence of gp83 ligand, resulting in high
parasite multiplication at 72 h. These observations together with
the fact that knocking down the expression of LAMC1 by RNAi
dramatically reduces T. cruzi attachment, entry and multiplication
within cells strongly support the hypothesis that host LAMC1,
which is regulated by the parasite gp83, plays a crucial role in the
early process of cellular infection.
The regulation of infection by the gp83 ligand represents a par-
asite escape mechanism in which invasive trypomastigotes release
gp83 to efﬁciently gain entry into human coronary artery smooth
muscle (HCASM)cells bymanipulatingLAMC1,which is themost
abundant isoform of laminin in humans (Sasaki et al., 2004).
Trypanosoma cruzi must navigate through the basal lamina,
which contains LAMC1, and surrounds individual muscle cells
such as HCASM cells before infecting these cells. The fact that a
T. cruzi trypomastigote ligand increases LAMC1 transcript levels
in HCASM cells, correlates well with the ﬁnding that laminin is
deposited in the hearts of patients infected with Chagas’ disease
(Milei et al., 1993). This suggests that the regulation of LAMC1 in
heart cells by gp83 may be involved in heart pathology.
Since the T. cruzi gp83 ligand remodels the ECM by up-
regulating the expression of LAMC1, together with the report
that T. cruzi presents laminin receptors on its surface (Gior-
dano et al., 1999), indicates that the parasite exploits LAMC1 to
navigate through the ECM, recruit trypanosomes and facilitate
infection. Thus, the T. cruzi gp83 ligand is a virulence factor that
modiﬁes LAMC1 expression in the ECM and contributes to the
pathogenesis of T. cruzi infection in human heart cells.
T. cruzi MODULATES THE LAMC1 SUB-NETWORK
Recently, the ﬁrst LAMC1 sub-network modulated by invasive
trypomastigotes during the early process of infection was eluci-
dated (Nde et al., 2010). To populate and build the interaction
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network, the Michigan Molecular Interactions (MiMI) cytoscape
plugin (version 3.2) was used. MiMI retrieves molecular interac-
tions from MiMI database and displays the interaction network
with cytoscape. MiMI gathers and merges data from well-known
protein interaction databases including BIND, DIP, HPRD, Ref-
Seq, SwissProt, IPI, and CCSB-HI1. The plugin also integrates
with other NCBI tools for literature information, document sum-
marization, and pathwaymatching (Gao et al., 2009). The RT-PCR
veriﬁed transcripts were used as the initial population nodes.
MiMI was used to query for the initial nodes and their respec-
tive nearest neighbors to one degree. The networks were then
merged for interconnections and the interactome was visualized
in cytoscape (version 2.6.1) using the yFiles: organic layout format
(Cline et al., 2007).
The ﬁrst elucidated LAMC1 sub-network interactome mobi-
lized in cells by T. cruzi involves the following genes CCDC53,
NID1, NID2, SNAPIN, LAMA1, SV2A, CD44, LAMA5, ATF71P,
ITGB4, LAMB1, LAMB2, SV2C, SV2B, ITGA6, and BCL6 (Nde
et al., 2010). Our group is fully investigating the roles of the mem-
bers of this sub-network in the infection process. Accordingly, the
ITGA6 gene that encodes integrin alpha-6 that combines with beta
4 as a laminin receptor, or with beta 1 in the integrin VLA-6 par-
ticipates in cell adhesion as well as cell-surface mediated signaling.
The integrin, beta 4 (ITGB4) gene that encodes the integrin beta 4
subunit, a receptor for the laminins, tends to associate with alpha
6 subunit and appears to be involved in cell invasion. Entactin,
also known as nidogen-1 (NID1) is a component of the basement
membrane that connects the networks formed by collagens and
laminins to each other and plays a role in cell interactions with
the ECM. Furthermore, LAMA1 (Laminin, alpha 1) interacts with
Fibulin-2 (FBLN2), an ECM protein that binds various extracellu-
lar ligands and calcium and appears to be involved in the infection
process. Interestingly, BCL6 is a central hub of the interaction
LAMC1 sub-network, which is also a common central hub to ﬁve
of the seven sub-networks reported by one degree of connection
to the initial seed nodes (Nde et al., 2010).
The elucidation of the LAMC1 sub-network interactomemobi-
lized byT. cruzi is critically important to understand the molecular
pathogenesis of T. cruzi infection derived from the ECM/T. cruzi
gp83 ligand interplay and for the development of approaches for
intervention.We expect that continuing to explore systems biology
in the early process of T. cruzi infection will rapidly bring novel
approaches for the treatment and management of Chagas disease.
THBS1 INTERACTS WITH T. cruzi SURFACE CALRETICULIN
TO ENHANCE CELLULAR INFECTION
Thrombospondins have been described as“matricellular proteins”
because they play a role in regulating cellular responses and ECM
remodeling in the pericellular microenvironment but they are
non-essential components of the mature matrix ﬁbrils (Born-
stein, 2002). The role of THBS1 in vitro and in vivo is complex
and context speciﬁc, because it interacts with a wide array of
cellular proteins. THBS1 is a large homotrimeric glycoprotein
containing several domains that can bind to cell surface recep-
tors and extracellular molecules (Chen et al., 2000) such as the
N-terminal heparin-binding domain (NTSP), procollagen region,
type 1, 2, and 3 repeats and a C-terminal domain (Elzie and
Murphy-Ullrich, 2004). The molecule also contains highly con-
served epidermal growth factor (EGF) repeats, type 3 repeats and
a C-terminal domain, which includes the signature domain (Carl-
son et al., 2005) that can interact with integrins and CD47 (Lawler
and Hynes, 1989; Gao and Frazier, 1994). The C-terminal domain
of the thrombospondin family is highly conserved compared to the
N-terminal domain, which is different for each thrombospondin
isoform.
Calreticulin (CRT) is a major intracellular well-conserved
calcium-binding chaperone, which was identiﬁed in skeletal mus-
cle (Michalak et al., 1992) and is present in the cells of all
higher organisms except erythrocytes (Michalak et al., 1999; John-
son et al., 2001a,b). Numerous reports have implicated CRT
in several cellular functions and the molecule has signiﬁcant
non-endoplasmic reticulum functions in normal physiology and
human disease status (Gold et al., 2010).
Calreticulin has also been described in some parasite species
such as Schistosoma mansoni, Onchocerca volvulus, Necator amer-
icanus, Leishmania donovani, and Plasmodium falciparum. How-
ever, the role that this protein might play in parasite interactions
with the host immediate microenvironment remains unknown
(Nakhasi et al., 1998; Ferreira et al., 2004, 2005).
Previous studies from our group showed that invasive T. cruzi
trypomastigotes up-regulate the expression of THBS1 in HCASM
cells (Simmons et al., 2006). Furthermore, knockdown of THBS1
rendered mammalian cells less susceptible to cellular infection by
T. cruzi indicating that THBS1 also plays an important role in the
process of cellular infection by T. cruzi. However, the mechanisms
by which THBS1 is up-regulated by the parasite to modulate cellu-
lar infection are not completely known. The elucidation of T. cruzi
surface molecules that interact with THBS1 to enhance cellular
infection will advance our understanding of the molecular patho-
genesis of T. cruzi infection. We anticipated that NTSP, which is
speciﬁc to this isoform of thrombospondin, would be essential
in the interaction with the parasite because it is different for all
thrombospondin isoforms compared to the conserved C-terminal
domain (Carlson et al., 2005).
In T. cruzi, it has been suggested that the parasite surface CRT
(TcCRT; Ferreira et al., 2004; Aguilar et al., 2005) could play a role
in enabling the pathogen to evade the host immune response by
interactingwith theC1q component of complement (Aguilar et al.,
2005). The mechanism by which the parasite CRT interacts with
host proteins to enhance the process of cellular invasion remains
unknown. We recently hypothesized that T. cruzi uses its surface
TcCRT to exploit matricellular proteins regulated by the parasite
to enhance cellular infection.
We recently reported that T. cruzi up-regulates the expression
of THBS1 to enhance the process of cellular invasion.Very recently
our group characterized a novel THBS1 interaction with T. cruzi
that enhances cellular infection (Johnson et al., 2012). We showed
that labeledTHBS1 interacts speciﬁcallywith the surface of T. cruzi
trypomastigotes. In Figure 1 we show the full-length THBS1
and the NTSP domain that interact with TcCRT. Pre-exposure
of recombinant NTSP or THBS1 to T. cruzi signiﬁcantly enhanced
cellular infection of wild-type mouse embryo ﬁbroblasts (MEF)
compared to the C-terminal domain of THBS1, E3T3C1. In addi-
tion, blocking TcCRT with antibodies signiﬁcantly inhibited the
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FIGURE 1 |THBS1 structure and NTSP domain that interacts withTcCRT to enhanceT. cruzi cellular infection.
enhancement of cellular infectionmediated by the TcCRT–THBS1
interaction. Taken together, these ﬁndings indicate that THBS1
interacts with TcCRT on the surface of T. cruzi through the NTSP
domain and that this interaction enhances cellular infection. Thus,
surface TcCRT is another virulence factor that enhances the patho-
genesis of T. cruzi infection through THBS1, which is up-regulated
by the parasite.
The observation that THBS1 interacts with the parasite mem-
brane TcCRT is also in agreement with the recent discovery that
CRT, which was previously thought to be exclusively intracellu-
lar, is also expressed on the surface of the parasite (Arosa et al.,
1999; Xiao et al., 1999; Yan et al., 2010). The identiﬁcation of CRT
homologs in other parasites such as Onchocerca, Schistosoma, and
Leishmania (Michalak et al., 1992; Nash et al., 1994; Joshi et al.,
1996) suggests that the protein functions as an intracellular chap-
erone but its role in the process of infection of those parasites
remains unknown.
Our group showed that surface TcCRT is a virulence factor
that interacts with host THBS1 to enhance cellular infection by
T. cruzi (Johnson et al., 2012). In order to explore the signiﬁcance
of host THBS1 and TcCRT in cellular infection by T. cruzi, our
group used THBS1 KO MEF and WT MEF in infection assays.
We observed that host THBS1 and parasite surface TcCRT are
important for MEF cellular infection by T. cruzi. The signiﬁcance
of surface TcCRT in enhancing cellular infection by T. cruzi was
supported by the fact that speciﬁc antibodies to TcCRT signiﬁ-
cantly reduced cellular infection. The identiﬁcation of TcCRT as
a virulence factor expressed on the surface of the parasite can be
exploited to provide new insights into the molecular pathogene-
sis of T. cruzi infection. TcCRT expression on the parasite surface
may modulate the vertebrate complement system as an immune
escape mechanism (Ferreira et al., 2005). Taken together, these
ﬁndings indicate that THBS1 interacts with TcCRT on the surface
of T. cruzi through the NTSP domain and that this interaction
enhances cellular infection by T. cruzi.
T. cruzi MODULATES THE THBS1 SUB-NETWORK
The matricellular THBS1 glycoprotein inhibits angiogenesis and
modulates endothelial cell adhesion, motility, and growth.
THBS1 interacts with several cell adhesion receptors, including
CD36, integrins, and integrin-associated proteins and inhibits
matrix metalloproteinase enzymes thereby remodeling the cel-
lular microenvironment (Sid et al., 2004). We have shown that
T. cruzi up-regulates the expression of THBS1 to facilitate the
invasion process (Simmons et al., 2006). Knockdown of THBS1
by RNAi signiﬁcantly inhibited cellular invasion by T. cruzi. The
increased level of THBS1 expression signiﬁcantly modulates the
interactome cross-talk between the cells, as we found the largest
protein–protein interaction (PPI) sub-network occurred in the
THBS1 seednetwork,with 51nodes interconnectedwith 151 edges
(Nde et al., 2010). This network topologywill potentially favor par-
asite multiplication and survival. During this cross-talk, higher
levels of THBS1 activate TGF-β (Ribeiro et al., 1999), a major
pro-ﬁbrotic cytokine causing modiﬁcation of the ECM milieu.
THBS1 then interacts with several host proteins including the
COL7A1 gene product, which then interacts with other proteins
from the laminin family of genes to make the ECM conducive
to parasite mobility and cellular invasion. The modulation of
THBS1 gene networking proﬁle is highly critical for trypanosome
mobility and cellular invasion. Other parasites (including the
human pathogens Plasmodium, Toxoplasma, and Cryptosporid-
ium), which do not regulate human THBS1, use a transmembrane
thrombospondin-related anonymous protein (TRAP) for gliding
motility and invasion of vertebrate host cells (Kappe et al., 1999;
Sibley, 2004; Morahan et al., 2009). TRAP proteins produced
by the parasite can also activate TGF-β, an anti-inﬂammatory
cytokine that counteracts the effects of inﬂammatory cytokines
like IL-12, INF-γ, and TNF-α thereby facilitating parasite sur-
vival. TSP1, also binds to matrix metalloproteinase-2(MMP-2)
and appears to be involved in the infection process.
Modulation of THBS1 expression in HCASM cells by T. cruzi
is essential because THBS1 blocks the cytoprotective activity of
nitric oxide (NO) by antagonizing the NO/cGMP signaling path-
way thereby negatively regulating vascular tone, vascular smooth
muscle cells adhesion, chemotaxis, and proliferation (Isenberg
et al., 2008). Increased THBS1 transcripts in parasitized HCASM
cellsmay suggest that THBS1 also contributes in part to the pathol-
ogy caused by T. cruzi. THBS1 is required for the infection process
of T. cruzi as evidenced by RNAi of that speciﬁc isoform. The up-
regulation of host THBS1 expression by T. cruzi to facilitate the
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infection of human cells represents an additional mechanism that
contributes to the pathogenesis of T. cruzi infection.
The ﬁrst elucidated THBS1 sub-network interactome mobi-
lized in cells by T. cruzi involves the following genes: TSC2,
TNFRSF1A, COL1A1, COL2A1, COL3A1, COL5A1, COL7A1,
SDC1, SDC2, SDC3, SCD4, SPARC, LTBP1, HRG, ITGB1, ITGB3,
ITGA3, ITGA4, ITGAV, FGA, SPP1, F2, CD47, MMP2, MMP9,
CALR, TFPI, ZNF8, LRP1, LRP5, TP53, CTSG, PDGFB, ELA2,
CORO1A, LAMB3, CFH, PDEA, JAG1, DCN, TGFB1, CD36,
FN1, PLG, TNFAIP6, SCARB2, DHFR, and KNG1 (Nde et al.,
2010). The roles of the members of the THBS1 sub-network in the
infection process are also being investigated fully by our group as
indicated above in this section. The new advances in the area will
facilitate the identiﬁcation of the molecular signature induced by
T. cruzi in cells via the TcCRT–THBS1 interphase as well as the
development of small molecule inhibitors to interrupt the critical
initial steps of T. cruzi infection.
T. cruzi USES LAMININ AND GALECTIN-3 TO PROMOTE
CELLULAR INFECTION
The ECM, human lectins, and parasite mucins have been shown
to play an important role in the early process of T. cruzi infection.
Accordingly, human galectin-3 binds to a trypomastigote surface
mucin (Moody et al., 2000; Turner et al., 2002) and toHCASMcells
in a lectin-like manner (Kleshchenko et al., 2004) to signiﬁcantly
increase the adhesion of trypomastigotes to these cells. Silencing
galectin-3 expression in cells by antisense approach signiﬁcantly
reduces trypomastigote cell adhesion. Galectin-3 molecules inter-
act with a T. cruzi 45 kDA mucin surface protein on one hand
and with laminin on the other, via their carbohydrate recognition
domains and are joined together through the R-domains (Moody
et al., 2000; Kleshchenko et al., 2004). In this way, galectin-3 binds
to laminin and trypomastigotes to recruit them to the ECM thus
facilitating initial infection. Thus, galectin-3 provides a bridge
between parasites and laminin in host cell thereby enhancing
infection. Prior to cellular infection the infective trypomastig-
otes bombard host cells with PLC-cleaved gp83 to activate the
ERK1/2 pathway to up regulate laminin primed cells to enhanced
infection via the laminin-45 mucin-galectin-3 pathway (Moody
et al., 2000; Kleshchenko et al., 2004). These studies pointed out
a novel T. cruzi–host cell interaction mediated by gp83-laminin-
45 mucin- galectin-3 that recruits signiﬁcant number of parasites
at the ECM to facilitate cellular infection. Other T. cruzi surface
antigens bind to laminin (Giordano et al., 1999) and ﬁbronectin
(Ouaissi et al., 1986) and have been postulated to participate in the
infection process, however these interactions have not been stud-
ied using systems biology approaches. Overall, we can conclude
that the parasite modulates some ECM components and inter-
acts with them to facilitate infection by exploiting these molecules
and human lectins to recruit parasites in the early process of
infection.
Galectin-3 binds to the surface of HCASM cells in a granular
manner, distributed around the cellular membrane, polarized, and
more pronounced at the cellular ends (Kleshchenko et al., 2004).
The receptors for human galectin-3 are distributed in patches
on the cell surface and are more abundant at the cellular ter-
minal regions. The binding of galectin-3 to trypomastigotes is
also seen as granular, restricted to some areas of the trypanosome
membrane, and polarized (Kleshchenko et al., 2004).
Galectin-3 is also implicated in the association of T. cruzi
trypomastigotes with laminin (Moody et al., 2000). Binding of
trypomastigotes to laminin is enhanced by galectin-3 and this
enhanced binding of trypanosomes is inhibited by lactose. Co-
immunoprecipitations indicate that galectin-3 binds to the 45
kDa trypomastigote surface protein and this binding is also inhib-
ited by lactose (Moody et al., 2000). The monoclonal antibody
B5 that recognizes the trypomastigote 45 kDa surface mucin
blocks trypomastigote attachment to heart myoblasts (Moody
et al., 2000; Turner et al., 2002). A working model proposes that
galectin-3, released by human cells, forms bridges between T.
cruzi and laminin. Since nearly all the tissues which T. cruzi
infects are surrounded by basement membranes of which laminin
is a major constituent, its ability to effectively interact with
laminin is critically important for passage through the membrane
barrier. These studies suggest that this is a trypanosome trap-
ping mechanism, which enables the organisms to accumulate in
the basement membrane prior to invasion of heart myoblasts,
making galectin-3 a candidate molecule, which enhances the
pathogenesis of T. cruzi via laminin and a T. cruzi surface
mucin.
Galectins have long been suspected of modulating cell to ECM
interactions in a novel fashion (Liu and Rabinovich, 2005). Data
suggest that one mechanism involves the ligation of mammalian
cells to ECM proteins, which also interact with galectin-3 such as
laminin and elastin (Liu and Rabinovich, 2005). The other mecha-
nism involves the interaction of galectins with the polylactosamine
residues of integrins, resulting in the modulation of cellular adhe-
sion to ECM proteins (Rabinovich et al., 2002). Whereas most of
these studies were done in mammalian systems, it has been sug-
gested that galectins expressed by Entamoeba may be critical in
their interactions with host cells (Petri et al., 1990). It is likely
that in parasitic organisms, the binding of the organisms to the
ECM proteins or cell surface glycoconjugates may be the primary
adhesion mechanisms mediated by galectins.
Galectin-3 is also expressed in B cells from T. cruzi-infected
mice (Acosta-Rodríguez et al., 2004) and is up-regulated by T.
cruzi infection of mice (Vray et al., 2004). The fact that galectin-
3 is secreted by macrophages and by other cells, including
HCASM cells, suggests that released galectin-3 modulates infec-
tion via laminin. The concentrations of galectin-3 that increase
trypanosome adhesion to HCASM cells in vitro are similar to
the concentrations of galectin-3 present in ﬂuids in vivo (Sano
et al., 2000). Furthermore, the concentrations of galectin-3 in
ﬂuids in vivo increase approximately 300-fold during microbial
infection (Sato and Hughes, 1994). These observations suggest
that the parasite may have adapted to the host and that it
takes advantage of a host inﬂammatory molecule, galectin-3, to
bind to host cells via laminin and a T. cruzi mucin to enhance
infection.
Previous studies have shown that parasite molecules bind
to immobilized laminin (Giordano et al., 1999) and that
human galectin-3 enhances this interaction (Moody et al., 2000),
indicating that the trypanosome interacts with laminin via
galectin-3.
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T. cruzi SURFACE GP83 REGULATES THE ECM INTERACTOME
The genetic architecture of the early T. cruzi infection process
of human cells is very limited. To understand this aspect of the
infection, we conducted gene transcription microarray analysis
followed by gene network construction of the host cell response in
primary HCASM cells infected with T. cruzi or exposed to T. cruzi
gp83. Using THBS1, LAMC1, LGALS3, and ERK1/2 as the seed
nodes for biological network construction,webuilt an interactome
network of the early T. cruzi infection process, which centered on
the ECM. ERK1/2 was used as one seed mode, since T. cruzi gp83
activates ERK1/2 in cells to up-regulate the LAMC1 expression and
infection. After seeding the initial four nodes, the network was
expanded to one degree of direct biological interaction, result-
ing in base interaction networks with the seed node as a center
point in each. In order to populate and build our interaction
network we used a similar approach to determine the modula-
tion of the LAMC1 sub-network as indicated above. Figure 2
shows the ECM interactome that is modulated by T. cruzi gp83
ligand. The ﬁrst step in the regulation of the ECM interactome
by T. cruzi during the initial infection process involves triggering
gp83 receptors in the cell via activation of ERK1/2 by PLC-cleaved
gp83 which results in the up-regulation of LAMC1 and activa-
tion of the LAMC1 sub-network which directly cross-talks with
the LGALS3 sub-network to recruit parasites and enhance cellular
infection on one side. On the other side, triggering gp83 receptors
in the cell via ERK1/2 cross-talk with the THBS1 sub-network,
also enhances cellular infection and cross-talk at a distance with
LGALS3, which also recruit parasites via Tc45 mucin, and LAMC1
(Figure 2). Tc85 interacts with laminin and may mobilize the
ECM interactome. It is also possible that T. cruzi MMP9 like
FIGURE 2 |Trypanosoma cruzi gp83 regulates the ECM interactome
and trypanosome usage of the ECM during early infection to enhance
cellular infection.T. cruzi gp83 ligand triggers gp83 receptors in the cell via
ERK1/2 to up-regulate LAMC1 which cross-talks with LGALS3 andTHBS1 to
enhance cellular infection using selected parasite surface molecules such as
TcCRT,TC45 mucin, andTc85. Arrow points to the ﬁrst signal. The interactome
was generated using MiMI Cytoscape plugin (version 3.2). The MiMI interface
uses a database which is itself constructed from merged data of well-known
protein interaction databases as described in the text of the review. The
network was connected by using ERK1/2, Laminin gamma-1 (LAMC1),
Thrombospondin-1 (THBS1), and Galectin-3 (LGALS3) as initial seed nodes
(large DIAMOND nodes). Node expansion was done to one degree of
biological protein–protein interaction partners of the seed nodes using
the Michigan Molecular Interaction Database. Proteins mapping to the
canonical “ECM-Receptor Interaction Pathway” of KEGG (hsa04512) are
highlighted as following: GREEN nodes are ECM ligands (laminins,
collagens, ﬁbronectin, heparan sulfate, and thrombospondin-1). RED
nodes are ECM receptors: (integrins, cd35, cd47, and SV2A). BLUE
nodes are not part of the KEGG ECM–ECM Receptor Pathway, but have
established biological interactions with ECM–Receptor interaction nodes.
The global interactome was visualized in Cytoscape (version 2.6.3), yielding
the ECM interactome involved in earlyT. cruzi infection. Trypomastigotes
pointed in the ﬁgure are culture trypomastigotes released from infected
cells expressing surfaceTcgp83, TcCRT, andTc45 mucin. All of these
trypomastigote surface molecules are also expressed in blood
trypomastigotes.
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activity that degrades the ECM may regulate the ECM interactome
(Nogueira de Melo et al., 2010). This ECM-focused interactome
contains 108 nodes representing protein-coding genes connected
by 222 edges representing biological interactions between nodes
(Figure 2).
Increased THBS1 expression signiﬁcantly modulates the inter-
actome cross-talk between cells. This change in network topology
potentially favors parasite invasion and infection of host cells. As
such, THBS1 interacts with several proteins ranging from adhe-
sion receptors (CD36 and CD47) to structural proteins (COL7A1)
and zymogens. CD47 is a receptor for the C-terminal domain
of THBS1 and this interaction may be important in membrane
transport and signal transduction. In addition, CD47 is involved
in intracellular calcium increase, which occurs when the cell
adheres to the ECM. An increase in cytosolic Ca++ in T. cruzi
trypomastigotes was detected at the single cell level after asso-
ciation of the parasites with myoblasts. Ca++ mobilization in
host cells was also detected upon contact with trypomastigotes.
Conﬁrmatively, pretreatment of the parasiteswith theCa++ chela-
tors decreased trypomastigote association to myoblasts indicating
that calcium mobilization is required for cell invasion (Moreno
et al., 1994).
The structural protein COL7A1 is typically found in the base-
ment membrane and also associates with THBS1. Once COL7A1
interacts with THBS1, it makes the ECM conducive to parasite
motility and cellular invasion with the help of proteins from the
laminin family of genes. Plasminogen (PLG) links LAMC1 and
THBS1. PLG (a zymogen) is cleaved into plasmin (a serine pro-
tease), and angiostatin (an angiogenesis inhibitor). Plasmin is
known to cleave ﬁbronectin, THBS1, and LAMC1, thus taking
part in ECM modiﬁcations.
Trypanosoma cruzi must navigate through the basal lamina,
which contains LAMC1. TheT. cruzi gp83 ligandmodiﬁes LAMC1
expression in the ECM and contributes to the pathogenesis of
T. cruzi infection in human heart cells. The fact that the LAMC1
network is connected to THBS1 through PLG and COL7A1 and
matrix metalloproteinase 2 (MMP2) suggests that this network
could facilitate parasite mobilization. MMP2 is a type IV colla-
genase that participates in the rearrangement of the ECM, which
could facilitate parasite mobilization. In the LAMC1 sub-network
there is an indirect connection (through LAMA1) to dystroglycan
(DAG1). DAG1 is a dystrophin-associated glycol-protein respon-
sible for transmembrane linkage between the ECM and host cell
cytoskeleton. The extracellular form of DAG1 can bind to merosin
alpha-2-laminin in the ECM (Yamada et al., 1994). If T. cruzi alters
the dystroglycan complex, it could consequently manipulate or
weaken the host cell cytoskeleton prior to gaining entry into the
cell. This could yet be anothermechanismbywhichT. cruzi invades
host cells. In reference to the ECM network reviewed, LAMC1 also
has a second-degree interaction (one node in between the genes)
with LGALS3 through myocilin (MYOC). MYOC is a secreted
protein believed to have a role in cytoskeletal function, speciﬁ-
cally vesicular transport and ECM conformation (Caballero et al.,
2000). Unlike other intracellular pathogens, which avoid contact
with host cell lysosomes, T. cruzi requires the low-pH environ-
ment of lysosomes to initiate egression from the vacuole and
delivery to the host cell cytoplasm where replication takes place
(Burleigh, 2005). Therefore, the control of vesicular trafﬁcking by
T. cruzi improves the rate of trypomastigote entry and amastigote
replication in the host cell. The fact that LAMC1 is connected
to LGALS3 through MYOC in the ECM interactome suggests
the importance of LGALS3 in the manipulation of host ECM by
T. cruzi.
Increased LGALS3 expression in the ECM promotes the adhe-
sion of T. cruzi to host cells and subsequent infection (Kleshchenko
et al., 2004). In addition, LGALS3 has numerous ECM interact-
ing partners (Dumic et al., 2006), including collagen IV, hensin,
laminins, ﬁbronectin, vitronectin, tenascin, and elastin. LGALS3
regulates adhesion of these ECM proteins to a variety of host cells.
Matrix metalloproteases, which are more active in T. cruzi infected
mice, regulate LGAL3 function (Gutierrez et al., 2008). When met-
alloproteases are activated in the ECM, they can cleave LGALS3
and negatively regulate its function. Consequently, increased acti-
vation of MMP1 and MMP9 is associated with ECM destruction
and myocarditis in T. cruzi infection.
Multiple types of collagen interact with the three central seed
nodes, THBS1, LGALS3, and LAMC1. A glimpse of the impor-
tance of collagen in early T. cruzi infection was reported (Velge
et al., 1988).
SOME POTENTIAL IMPLICATIONS OF THE ECM IN INFECTION
Expression proﬁling microarray studies of T. cruzi infected cells
have shown that some ECM genes are regulated (Goldenberg
et al., 2009; Mukherjee et al., 2003), however those genes were not
conﬁrmed by RT-PCR, nor their function in the process of T.
cruzi infection was determined. Several reports suggest that some
parasite proteases may degrade the ECM. The possible role of
trypanosomatid surface proteases in parasite survival and infec-
tion has been discussed (Marino et al., 2003; Yao, 2010). It was
suggested that the gp85/trans-sialidase interacts with the ECM
components (Alves and Colli, 2008) and speculated that the pro-
lyl oligopeptidase Tc 80 may be involved in the infection possibly
by acting on ECM components (Grellier et al., 2001). Interest-
ingly, it was found that in a T. cruzi infected mouse embryo
hepatocyte cell line, there was a reduction of MMP9 (Nogueira
de Melo et al., 2004), as well as some matrix components during
the late phase of infection (60th to 90th day; Magalhaes-Santos
et al., 2002). Pinho et al. (2002) reported that uncharacterized
parasite antigens bind to non-infected cells and that ECM com-
ponents were recognized by antibodies, however the molecular
characterization of antigens and the speciﬁcity of these possi-
ble interactions were not considered. Furthermore, Santana et al.
(1997) showed that a Tc 80 proteinase hydrolyzes collagen type in
rat mesentery. It is possible that that ECM derived from T. cruzi
infected endothelial cells directs phenotypic expression (Morris
et al., 1990).
It has been suggested that there are ﬁbrotic implications during
T. cruzi infection involving the ECM. Accordingly, Calvet et al.
(2009) suggested that TGF-β and TNF-α stimulate ﬁbronectin
expression in uninfected cells of T. cruzi-infected cultures, whereas
cells harboring the parasites display low or no ﬁbronectin ﬁbrils.
It was observed that there are sequential changes of the connective
matrix components of the myocardium (ﬁbronectin and laminin)
duringﬁbrosis in infectedmice (Andrade et al., 1989). The fact that
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T. cruzi-mediated down-regulation of CTGF expression requires
de novo host cell protein synthesis and that T. cruzi interferes with
the host ﬁbrogenic response suggest that this complex process
requires input from multiple host cell signaling pathways (Unnikr-
ishnan and Burleigh, 2004). Although it has been demonstrated
that cardiomyocytes are able to synthesize cytokines upon T. cruzi
infection, Calvet et al. (2004) suggest that matrix remodeling is
dependent on cytokines secreted by inﬂammatory cells recruited
in immune response. These reports suggest thatT. cruzi modulates
the ECM during the infection process with potential implications
in the pathology of the disease.
CONCLUDING REMARKS
Despite an appreciation of the involvement of the ECM in T. cruzi
infection, the difﬁculty in delineating regulatory networks in the
process of cellular infection and disease, has until now prevented
a comprehensive assessment of T. cruzi infection at the molecu-
lar level. The use of systems biology approaches to elucidate the
ECM interactome network regulated by T. cruzi and its gp83 lig-
and that mediate trypanosome attachment and entry are critically
important to understand the molecular pathogenesis of T. cruzi
infection and to design novel approaches for intervention and dis-
ease management. There is an expectation that systems biology
approaches applied to understand T. cruzi infection would bring
new innovative strategies for the treatment and control of Chagas
disease. So far the use of systems biology to understand the role
of the ECM in T. cruzi infection has signiﬁcantly enhanced the
understanding of T. cruzi–host cell interaction and pathogenesis
of T. cruzi infection. Accordingly, here we elucidate the ﬁrst ECM
interactome triggered by the T. cruzi gp83 ligand during the ﬁrst
step of cellular infection to recruit trypanosomes at the ECM to
enhance cellular infection. In the shot gun used by T. cruzi to reg-
ulate the ECM interactome to gain cellular entry and evade the
host reported here,T. cruzi gp83 triggers gp83 receptors in the cell
via ERK1/2 to up-regulate LAMC1 which cross-talks with both
LGALS3 and THBS1 to enhance cellular infection using selected
parasite surface molecules such as TcCRT and TC45 mucin. Based
on this new information, current efforts are being pursued by our
group to elucidate the molecular signature induced by T. cruzi in
cells. Since T. cruzi–host cell interaction is of a complex nature,
the elucidation of the global interactome and sub-interactome
networks will help understand the complex T. cruzi–host inter-
phase that mediate parasite attachment and entry, and develop
new means for the treatment of the highly neglected and complex
Chagas disease, which has no current effective drugs or vaccines.
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